Related Experiment Videos
Rotavirus vaccines--from licensure to disease reduction
W A Orenstein1, S Hadler, J N Kuritsky
1National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
The Journal of Infectious Diseases
|September 1, 1996
Summary
Rotavirus vaccines offer significant potential to reduce the serious health burden of rotavirus infection in the United States. Successful implementation requires recommendation, funding, and integration into routine childhood immunizations, alongside ongoing safety and impact monitoring.
Area of Science:
- Public Health
- Vaccinology
- Infectious Diseases
Background:
- Rotavirus infection causes a substantial health burden in the U.S., with over 100,000 hospitalizations and 100 deaths annually.
- This burden is comparable to pre-vaccine rates of other preventable childhood diseases like measles and pertussis.
Purpose of the Study:
- To highlight the potential of rotavirus vaccines to alleviate a significant public health problem.
- To outline the necessary steps beyond vaccine licensure for effective disease prevention.
Main Methods:
- This study is a review and analysis of the public health impact of rotavirus and the implementation requirements for rotavirus vaccines.
- It synthesizes information on disease burden, vaccine potential, and post-licensure strategies.
Main Results:
- Rotavirus vaccines represent a major breakthrough in preventing severe rotavirus disease.
- Successful disease reduction hinges on vaccine recommendation, financing, integration into schedules, equitable access, and robust monitoring.
Conclusions:
- Vaccine licensure is the initial step; comprehensive implementation strategies are crucial for realizing the full public health benefits of rotavirus vaccines.
- Ongoing evaluation of vaccine safety and disease impact is essential for refining prevention strategies.